Revolution Price Sales Ratio from 2010 to 2024

RVMDW Stock   0.34  0.01  2.86%   
Revolution Medicines, Price Sales Ratio yearly trend continues to be fairly stable with very little volatility. Price Sales Ratio is likely to outpace its year average in 2024. During the period from 2010 to 2024, Revolution Medicines, Price Sales Ratio regression line of quarterly data had mean square error of  4,750 and geometric mean of  65.37. View All Fundamentals
 
Price Sales Ratio  
First Reported
2010-12-31
Previous Quarter
280.23646312
Current Value
294.25
Quarterly Volatility
82.86418453
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Revolution Medicines, financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Revolution Medicines,'s main balance sheet or income statement drivers, such as Net Interest Income of 49.5 M, Interest Income of 49.9 M or Interest Expense of 287.9 K, as well as many indicators such as Price To Sales Ratio of 294, Dividend Yield of 0.0 or PTB Ratio of 1.69. Revolution financial statements analysis is a perfect complement when working with Revolution Medicines, Valuation or Volatility modules.
  
Check out the analysis of Revolution Medicines, Correlation against competitors.

Latest Revolution Medicines,'s Price Sales Ratio Growth Pattern

Below is the plot of the Price Sales Ratio of Revolution Medicines, Warrant over the last few years. It is Revolution Medicines,'s Price Sales Ratio historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Revolution Medicines,'s overall financial position and show how it may be relating to other accounts over time.
Price Sales Ratio10 Years Trend
Slightly volatile
   Price Sales Ratio   
       Timeline  

Revolution Price Sales Ratio Regression Statistics

Arithmetic Mean83.80
Geometric Mean65.37
Coefficient Of Variation98.88
Mean Deviation54.25
Median52.27
Standard Deviation82.86
Sample Variance6,866
Range260
R-Value0.60
Mean Square Error4,750
R-Squared0.36
Significance0.02
Slope11.08
Total Sum of Squares96,131

Revolution Price Sales Ratio History

2024 294.25
2023 280.24
2022 54.28
2021 62.35
2020 61.34
2019 34.07

About Revolution Medicines, Financial Statements

Revolution Medicines, investors use historical fundamental indicators, such as Revolution Medicines,'s Price Sales Ratio, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Revolution Medicines,. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Price Sales Ratio 280.24  294.25 

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Revolution Stock Analysis

When running Revolution Medicines,'s price analysis, check to measure Revolution Medicines,'s market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Revolution Medicines, is operating at the current time. Most of Revolution Medicines,'s value examination focuses on studying past and present price action to predict the probability of Revolution Medicines,'s future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Revolution Medicines,'s price. Additionally, you may evaluate how the addition of Revolution Medicines, to your portfolios can decrease your overall portfolio volatility.